Jim Chalmers may not be winning friends in boardrooms, but the $30 billion Santos bid could be a chance to show he’s serious about foreign investment.
Latest briefings
Senior Australian economists believe the spike in oil prices driven by the Israel-Iran war will prove short-lived.
Private credit targets higher returns through higher risk. But research shows investors haven’t seen value over the full cycle since the GFC.
ASIC to demand greater disclosure of private credit deals
New data shows HR tech and edtech are hit hardest, but impact startups focused on social and environmental issues are proving more resilient.
Equity has gone from fringe benefit to frontline strategy — and it may be Australia’s best bet for keeping talent and building global tech winners.
Foxtel has cut Kayo’s content production team as new owner DAZN begins reshaping the streamer to maximise its investment.
As Amazon doubles its Australian data centre investment, Capital Brief visited the Austin lab where another key piece of its AI push is taking shape.
Amazon pledges $20b investment in Australia’s data centre infrastructure
The private credit giant is embarking on an ambitious push into consumer lending in a bid to increase its scale and diversify its offering for investors.
Who is Elbridge Colby, the Trump ally reviewing AUKUS?
Donald Trump's undersecretary of defense for policy is leading a review of AUKUS — and his doubts could reshape Australia’s most ambitious military pact.
Oaktree's Howard Marks says that despite its current turmoil, America is still the best place to deploy capital. Some of his market compatriots are less sure.
Former iflix CEO Mark Britt has emerged from stealth mode with tmrw, an AI-driven preventive health platform which has already made one acquisition in the wellness space.
Zhou, who runs five pharmacies through his Aceso Group, said he was aided with a $1 million loan from StrongRoom AI investor EVP.
The government’s failure to act on AI is hurting productivity and living standards — Australia needs a clear, urgent strategy, not more delays and summits.
The Los Angeles-based AI firm is in talks with Australian publishers after finalising deals with the men's publisher Man of Many and the New Zealand publisher Stuff.
The sale of 23andMe's genetic database to Regeneron shows gaps in Australia's cross-border data protection laws for sensitive health information.
The Samuel Griffith Society is modelling itself on the US Federalist Society, while facing backlash for hosting disgraced former judge Dyson Heydon.
Four months after an investment into a pharmacy software startup went sour, the Sydney venture capital firm has used a series of legal moves to salvage what looked like a total loss.
